Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Grogan

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|June 19, 1991
Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicityR J Scheper, W S Dalton, T M Grogan, et al.
The American Journal of Pathology|March 1, 1993
An in vivo model of human multidrug-resistant multiple myeloma in SCID miceW T Bellamy, A Odeleye, P Finley, et al.
Blood|September 1, 1985
Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal changeB G Durie, E Vela, V Baum, et al.
Ultrastructural Pathology|January 11, 1992
A multidisciplinary approach to the diagnosis of cutaneous T-cell lymphomasC M Payne, T M Grogan, C M Spier, et al.
The American Journal of Dermatopathology|October 1, 1988
Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cellC M Payne, C M Spier, T M Grogan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1992
Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiencyC W Taylor, T M Grogan, M H Lopez, et al.
Cancer|February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group studyW S Dalton, J J Crowley, S S Salmon, et al.
Cancer|March 1, 1987
Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphomaS M Lippman, T M Grogan, C M Spier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsetsC P Leith, C M Spier, T M Grogan, et al.
Blood|January 15, 1993
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapyT M Grogan, C M Spier, S E Salmon, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|June 19, 1991
Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicityR J Scheper, W S Dalton, T M Grogan, et al.
The American Journal of Pathology|March 1, 1993
An in vivo model of human multidrug-resistant multiple myeloma in SCID miceW T Bellamy, A Odeleye, P Finley, et al.
Blood|September 1, 1985
Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal changeB G Durie, E Vela, V Baum, et al.
Ultrastructural Pathology|January 11, 1992
A multidisciplinary approach to the diagnosis of cutaneous T-cell lymphomasC M Payne, T M Grogan, C M Spier, et al.
The American Journal of Dermatopathology|October 1, 1988
Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cellC M Payne, C M Spier, T M Grogan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1992
Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiencyC W Taylor, T M Grogan, M H Lopez, et al.
Cancer|February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group studyW S Dalton, J J Crowley, S S Salmon, et al.
Cancer|March 1, 1987
Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphomaS M Lippman, T M Grogan, C M Spier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsetsC P Leith, C M Spier, T M Grogan, et al.
Blood|January 15, 1993
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapyT M Grogan, C M Spier, S E Salmon, et al.
Pageof 15